BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/30/2015 1:35:00 PM | Browse: 918 | Download: 1505
Publication Name World Journal of Gastroenterology
Manuscript ID 15847
Country/Territory Romania
Received
2014-12-12 08:26
Peer-Review Started
2014-12-12 09:58
To Make the First Decision
2015-01-22 16:37
Return for Revision
2015-02-02 10:21
Revised
2015-02-26 00:00
Second Decision
2015-04-07 17:12
Accepted by Journal Editor-in-Chief
2015-04-10 21:46
Accepted by Company Editor-in-Chief
2015-04-17 15:05
Articles in Press
2015-04-17 16:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-05-14 15:54
Publish the Manuscript Online
2015-05-30 13:32
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title New targeted therapies in pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Andrada Seicean, Livia Petrusel and Radu Seicean
Funding Agency and Grant Number
Corresponding Author Andrada Seicean, MD, PhD, Regional Institute of Gastroenterology and Hepatology, Iuliu Hatieganu University of Medicine and Pharmacy, 19-21 Croitorilor Street, Cluj-Napoca 400162, Romania. andradaseicean@gmail.com
Key Words Immunotherapy; Pancreas neoplasm; Vaccines
Core Tip Adjuvant therapy in pancreatic cancer has limited efficiency, and low survival rates are related to resistance to gemcitabine. New targeted therapies, such as passive immunotherapy, may have a role in combination with radiochemotherapy by targeting various protein kinases, as well as specific immunotherapies, such as vaccines, adoptive cell therapy and immunotherapy targeting tumor stem cells. In the future, treatments will likely include personalized medicine, tailored for numerous molecular therapeutic targets of multiple pathogenetic pathways.
Publish Date 2015-05-30 13:32
Citation Seicean A, Petrusel L, Seicean R. New targeted therapies in pancreatic cancer. World J Gastroenterol 2015; 21(20): 6127-6145
URL http://www.wjgnet.com/1007-9327/full/v21/i20/6127.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i20.6127
Full Article (PDF) WJG-21-6127.pdf
Full Article (Word) WJG-21-6127.doc
Manuscript File 15847-Review.docx
Answering Reviewers 15847-Answering reviewers.pdf
Audio Core Tip 15847-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 15847-Conflict-of-interest statement.pdf
Copyright License Agreement 15847-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 15847-Language certificate.pdf
Peer-review Report 15847-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 15847-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 15847-Scientific misconduct check.pdf
Scientific Editor Work List 15847-Scientific editor work list.pdf